EFG International AG purchased a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 22,439 shares of the conglomerate's stock, valued at approximately $16,155,000.
Other institutional investors also recently modified their holdings of the company. Ancora Advisors LLC bought a new position in Danaher during the 2nd quarter worth $1,332,000. Primecap Management Co. CA bought a new stake in shares of Danaher in the 2nd quarter valued at about $359,830,000. PDT Partners LLC acquired a new stake in shares of Danaher in the second quarter valued at about $2,808,000. Palisade Capital Management LP acquired a new stake in shares of Danaher in the second quarter valued at about $15,824,000. Finally, Canada Pension Plan Investment Board bought a new position in shares of Danaher during the second quarter worth about $32,918,000. Institutional investors own 79.05% of the company's stock.
Analyst Upgrades and Downgrades
DHR has been the topic of several analyst reports. Wells Fargo & Company reduced their target price on Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 22nd. Piper Sandler initiated coverage on shares of Danaher in a report on Thursday, June 11th. They set a "neutral" rating and a $200.00 price target for the company. TD Cowen dropped their price target on shares of Danaher from $240.00 to $236.00 and set a "buy" rating on the stock in a research report on Wednesday, July 22nd. Royal Bank Of Canada increased their price objective on shares of Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 22nd. Finally, DZ Bank began coverage on shares of Danaher in a research note on Wednesday, June 3rd. They set a "buy" rating and a $210.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $228.91.
Get Our Latest Stock Report on Danaher
Danaher Stock Up 0.3%
Danaher stock opened at $215.78 on Wednesday. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The firm has a market capitalization of $151.69 billion, a price-to-earnings ratio of 38.33, a price-to-earnings-growth ratio of 2.68 and a beta of 0.78. The firm's fifty day moving average price is $197.17 and its two-hundred day moving average price is $192.36. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.
Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business's revenue was up 5.5% on a year-over-year basis. During the same period last year, the company earned $0.77 earnings per share. On average, equities research analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.
About Danaher
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
